Impel Pharmaceuticals Inc.
IMPLNASDAQHealthcare
$0.04
$-0.02(-27.27%)
Market Cap$956000
P/E Ratio—
52W High$4.2
52W Low$0.0212
Impel Pharmaceuticals Inc. (IMPL) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IMPL · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | ($106.31M) | ($76.54M) | ($45.80M) | ($41.86M) |
| Depreciation & Amort. | $1.20M | $1.09M | $1.08M | $0.72M |
| Stock-Based Comp. | $5.19M | $3.13M | $3.64M | $0.79M |
| Change in Working Capital | ($13.01M) | $2.21M | $1.54M | $3.21M |
| Net Cash from Operations | ($93.64M) | ($66.36M) | ($39.18M) | ($36.49M) |
| Investing Activities | ||||
| Capital Expenditure | ($1.38M) | ($0.41M) | ($1.78M) | ($1.52M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($1.38M) | ($0.41M) | ($1.78M) | ($1.52M) |
| Financing Activities | ||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $67.46M | $147.89M | $11.06M | $0.02M |
| Free Cash Flow | ||||
| Free Cash Flow | ($95.02M) | ($66.77M) | ($40.97M) | ($38.01M) |
| FCF Margin %(computed) | -751.02% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Impel Pharmaceuticals Inc. data
About Impel Pharmaceuticals Inc. (IMPL) Cash Flow Statement
Impel Pharmaceuticals Inc. generated operating cash flow of ($0.09B) and free cash flow of ($0.10B) for 2022 — a FCF margin of -751.02%. Capital expenditure was ($0.00B).
Frequently asked questions
IMPL · 4 questionsImpel Pharmaceuticals Inc. generated free cash flow of ($0.10B) for 2022, down 42.3% year-over-year.
IMPL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10